The Hematology Journal

Login   |   Register

Open Journal Systems


Acute myocardial infarction in sickle cell disease: a possible complication of hydroxyurea treatment

André Fattori, Robenilson Almeida de Souza, Sara Terezinha Olalla Saad, Fernando Ferreira Costa


We describe a 28-year-old man treated with hydroxyurea for sickle cell anemia, who was admitted to the University Hospital with an acute myocardial infarction. The patient had evolved high hematocrit values during his long-term hydroxyurea treatment, suggesting a correlation between a possible increment in blood viscosity and the coronary occlusion without previous lesions. Indeed, several studies associate vasocclusive episodes and severe clinical course with high viscosity. Although hydroxyurea is considered an effective therapeutic option for these patients, care should be taken to monitor hematocrit levels and possible complications. Hematocrit and hemoglobin values of above 30% and 10.5 g/dl in SS patients on hydroxyurea therapy should be avoided or closely monitored.


sickle cell disease; hydroxyurea; myocardial infarction

Full Text:


Submitted: 2013-08-29 09:22:35
Search for citations in Google Scholar
Related articles: Google Scholar


  • There are currently no refbacks.


The Hematology Journal was merged with Haematologica in 2005.



© PAGEPress 2008-2013     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185